This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (15) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schaertl, S. Articles by Kramer, J. Search for Related Content PubMed PubMed Citation Articles by Schaertl, S. Articles by Kramer, J. Social Bookmarking                         What's this?

A Novel and Robust Homogeneous Fluorescence-Based Assay Using Nanoparticles for Pharmaceutical Screening and Diagnostics

EVOTEC BioSystems AG, Schnackenburgallee 114, 22525 Hamburg, Germany

Franz-Josef Meyer-Almes

EVOTEC Analytical Systems GmbH, Max-Planck-Strasse 15a, 40699 Erkrath, Germany

Eloisa Lopez-Calle

EVOTEC BioSystems AG, Schnackenburgallee 114, 22525 Hamburg, Germany

Adrian Siemers

EVOTEC BioSystems AG, Schnackenburgallee 114, 22525 Hamburg, Germany

Joachim Kramer

EVOTEC BioSystems AG, Schnackenburgallee 114, 22525 Hamburg, Germany

We have established a new type of homogeneous immunoassay based on nanoparticles (nanoparticle immunoassay, or NPIA) being analyzed using fluorescence intensity distribution analysis (FIDA). This method allows the characterization of single fluorescently labeled molecules or particles with respect to their molecular brightness and concentration. Upon binding of conjugates to molecules coupled to the nanoparticle surface, the brightness of the complex scales with the number of bound conjugates. The complexes can then be distinguished accurately from free conjugate and concentrations of free and bound molecules can be determined reliably. In this study we present various examples of NPIAs where capture antibodies were linked to the nanoparticles, which were either artificial beads or bacteria. Two assay formats have been developed; first, direct labeling of the conjugate was used to quantitate free antigen through competition experiments, and second, an antigen-directed antibody was labeled to establish an assay similar to a sandwich ELISA setup. The major advantages of a NPIA are the robustness and high signal-to-noise ratio at short measurement times, as demonstrated with a miniaturized experiment in a NanocarrierTM holding a volume of 1 µl/well. In addition to the good data quality, NPIAs are straightforward to perform because they require no washing steps. NPIAs open new dimensions for high throughput pharmaceutical screening and diagnostics. Assay development times can be reduced significantly because of a simple toolbox principle that is applicable to most types of assays.

Journal of Biomolecular Screening, Vol. 5, No. 4, 227-237 (2000)
DOI: 10.1177/108705710000500405


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				U. Haupts, M. Rudiger, S. Ashman, S. Turconi, R. Bingham, C. Wharton, J. Hutchinson, C. Carey, K. J. Moore, and A. J. Pope Single-Molecule Detection Technologies in Miniaturized High-Throughput Screening: Fluorescence Intensity Distribution Analysis J Biomol Screen, January 1, 2003; 8(1): 19 - 33. [Abstract] [PDF]